Inventiva (IVA) Other Non-Current Liabilities (2019 - 2025)
Inventiva (IVA) recorded quarterly Other Non-Current Liabilities of $1.4 million in Q4 2025, down 99.89% quarter-over-quarter from $1.3 billion in Q2 2025, and up 25.93% on a YoY basis from $1.1 million in Q4 2024.
Inventiva (IVA) Other Non-Current Liabilities (2019 - 2025) Analysis & Trends
Inventiva's Other Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $1.4 million for Q4 2025.
- In Q4 2025, Other Non-Current Liabilities rose 25.93% year-over-year to $1.4 million; the TTM figure through Dec 2025 stood at $1.4 million (up 25.93% YoY), while the FY2025 annual figure was $1.4 million, up 25.93% from the prior year.
- Other Non-Current Liabilities was $1.4 million for Q4 2025 at Inventiva, down from $1.3 billion in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $1.3 billion in Q2 2025 to a low of $1.1 million in Q4 2024.
- Historically, Other Non-Current Liabilities has averaged $214.0 million across 4 years, with a median of $2.1 million in 2021.
- The sharpest annual moves came in 2021 and 2024: Other Non-Current Liabilities surged 352.77% in 2021, then declined 0.68% in 2024.
- A 4-year view of Other Non-Current Liabilities shows it stood at $2.9 million in 2021, then slumped by 61.21% to $1.1 million in 2023, then retreated by 0.68% to $1.1 million in 2024, then climbed by 25.93% to $1.4 million in 2025.
- The last three Other Non-Current Liabilities figures came in at $1.4 million (Q4 2025), $1.3 billion (Q2 2025), and $1.1 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Inventiva | 8.93 Mn | -259.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.39 Mn |
| Jun 30, 2025 | 1.27 Bn |
| Dec 31, 2024 | 1.10 Mn |
| Dec 31, 2023 | 1.11 Mn |
| Jun 30, 2021 | 2.86 Mn |
| Mar 31, 2021 | 2.87 Mn |
| Dec 31, 2020 | 2.83 Mn |
| Jun 30, 2020 | 632,238.11 |
| Dec 31, 2019 | 635,353.52 |